Alone or with compression, Enluxtra Smart Wound Dressings can be used for accelerated wound drainage and odor reduction
HOW TO REDUCE WOUND DRAINAGE AND ODOR USING ENLUXTRA SMART WOUND DRESSINGS
Follow these steps:
* Compression therapy has two main functions: to counteract venous hypertension and to control edema [1]. In achieving these functions, exudate is reduced in the non-infected venous leg ulcer [2] [3]. In lymphedema the application of appropriate compression bandages or garments will result in reduction of both the limb edema and exudate leakage [4] [5].
- Rinse a wound with sterile saline or antiseptic wound cleanser before each dressing application.
- Choose the correct size of Enluxtra dressing. The dressing MUST cover fragile periwound area and overlap healthy skin by at least 1 inch (or more). Good contact with the wound bed must be maintained at all times. Refer to How to Use page for more information.
- Change Enluxtra every 1-2 days for the first 1-2 weeks, until drainage (and odor if present) is gradually reduced and slough/necrosis cleared.
- Then you may gradually increase wear time to 5-7 days, until the wound is healed.
* Compression therapy has two main functions: to counteract venous hypertension and to control edema [1]. In achieving these functions, exudate is reduced in the non-infected venous leg ulcer [2] [3]. In lymphedema the application of appropriate compression bandages or garments will result in reduction of both the limb edema and exudate leakage [4] [5].
WHY DOES IT WORK?
Production of wound exudate occurs as a result of vasodilation and increased vascular permeability during the inflammatory stage of healing under the influence of inflammatory mediators.
Aside from systemic factors that may support excessive exudate production (such as certain diseases and medications),
reduction of local wound inflammation, in most cases, is key to the reduction of exudate production.
reduction of local wound inflammation, in most cases, is key to the reduction of exudate production.
HOW TO DECREASE INFLAMMATION IN CHRONIC WOUNDS?
Chronic wounds frequently stall in the inflammatory stage, and do not progress to the proliferation stage.
It is a well-known fact that compromised immune system and the presence of excessive detritus, devitalized tissue, or microbial biofilm in the wound may both contribute to a prolonged inflammatory phase. The ongoing inflammation prevents the proper commencement of the proliferation phase of healing.
To move past the inflammation stage one has to consider bacterial burden, necrotic tissue, and moisture balance of the whole wound.
It is a well-known fact that compromised immune system and the presence of excessive detritus, devitalized tissue, or microbial biofilm in the wound may both contribute to a prolonged inflammatory phase. The ongoing inflammation prevents the proper commencement of the proliferation phase of healing.
To move past the inflammation stage one has to consider bacterial burden, necrotic tissue, and moisture balance of the whole wound.
- Bacterial overgrowth or infection need to be eliminated.
- Necrotic tissue, in most cases, needs to be debrided.
- Excessive exudate, high in toxic and pro-inflammatory components, needs to be continuously removed.
- Moisture balance needs to be maintained by moisturizing dry tissue and by drying wet tissue. *
WHAT IS THE CHALLENGE, WHY IS IT SO DIFFICULT SOMETIMES?
Wounds are non-uniform and constantly changing. By nature, every wound has different ever-changing areas that need different, dynamically changing care.
A wound may change quickly and unexpectedly in response to systemic processes taking place in the body; and nobody knows when this change happens, the process is unpredictable.
To be confident in the best possible outcome and to move past the inflammation stage, you should monitor the patient’s underlying diseases, correct nutritional issues, and perform wound offloading. But you also must address each wound area's dynamically changing needs continuously, separately, and simultaneously:
Until about four years ago, even well-trained clinicians were finding wound care challenging. They knew what they needed to do, but had no reliable means to do it.
* Wound care in the geriatric client.
Steve Gist, Iris Tio-Matos, Sharon Falzgraf, Shirley Cameron, and Michael Beebe Clin Interv Aging. 2009; 4: 269–287.
To be confident in the best possible outcome and to move past the inflammation stage, you should monitor the patient’s underlying diseases, correct nutritional issues, and perform wound offloading. But you also must address each wound area's dynamically changing needs continuously, separately, and simultaneously:
- Continuous selective wound cleansing: you have to continuously remove bacteria and prevent formation of biofilm; you also have to continuously remove non-viable tissues, such as slough and necrosis, from the wound bed with minimal trauma, while protecting delicate viable tissues.
- Continuous moisture balance maintenance: you have to moisten dry parts of the wound, while constantly removing harmful exudate from the exuding parts, and avoiding its transfer to non-exuding areas.
- Continuous wound protection: you also need to protect the wound from outside infection, and avoid its excessive exposure to the UV rays and low temperature.
Until about four years ago, even well-trained clinicians were finding wound care challenging. They knew what they needed to do, but had no reliable means to do it.
* Wound care in the geriatric client.
Steve Gist, Iris Tio-Matos, Sharon Falzgraf, Shirley Cameron, and Michael Beebe Clin Interv Aging. 2009; 4: 269–287.
HOW ENLUXTRA DOES THE JOB
Enluxtra Smart Self-Adaptive Wound Dressing is made of proprietary superabsorbent smart polymers. The dressing senses the underlying tissue's physical conditions and is able to adapt its local function to provide an optimal treatment for all different wound zones simultaneously.
1. Due to its super-absorbency, Enluxtra is able to absorb and lock away from the wound massive amounts of wound exudate along with its harmful components, salts, toxins, bacteria, and liquefied debris. Enluxtra does it exactly as needed, where needed and never overdries the wound bed. The powerful process works precisely over exuding parts of the wound, preventing exudate transfer to other parts and protecting vulnerable periwound skin.
2. At the same time, Enluxtra's adaptive hydration function takes care of the dry parts of the wound and periwound skin, keeping them properly hydrated under the dressing.
1. Due to its super-absorbency, Enluxtra is able to absorb and lock away from the wound massive amounts of wound exudate along with its harmful components, salts, toxins, bacteria, and liquefied debris. Enluxtra does it exactly as needed, where needed and never overdries the wound bed. The powerful process works precisely over exuding parts of the wound, preventing exudate transfer to other parts and protecting vulnerable periwound skin.
2. At the same time, Enluxtra's adaptive hydration function takes care of the dry parts of the wound and periwound skin, keeping them properly hydrated under the dressing.
3. When needed, these local adaptive absorption/hydration functions can be reversed and interchanged so, as the healing wound evolves, Enluxtra follows up. Click on the video to see how the process works inside Enluxtra.
4. Sustainable and balanced moist environment, quickly created by Enuxtra’s smart polymers, naturally supports fast autolysis of non-viable tissues. Autolytic process is selective, it works ONLY on non-viable tissues (slough,necrosis), never affects periwound skin and healthy tissues, and STOPS when the wound becomes clean.
5. Unlike all other dressings, Enluxtra is able to continuously evacuate liquefied products of the natural autolytic process, as well as other pro-inflammatory components, as needed, so the wound under Enluxtra quickly becomes clean, and stays clean. * This feature is unique to ENLUXTRA, no other product is able to continuously remove and lock in the debris and disintegrated biofilms from the wound bed.
The absorbed components are locked in the dressing and kept away from the wound. With every dressing change the amounts of slough and necrotic tissues in the wound are significantly reduced. Odor and exudate reduction typically follow.
* Wounds 2015;27(8):229-235 Volume 27 - Issue 8 - August 2015: EVIDENCE OF INTENSIVE AUTOLYTIC DEBRIDEMENT WITH A SELF-ADAPTIVE WOUND DRESSING Alexander M. Reyzelman, DPM and Mher Vartivarian, DPM
The absorbed components are locked in the dressing and kept away from the wound. With every dressing change the amounts of slough and necrotic tissues in the wound are significantly reduced. Odor and exudate reduction typically follow.
* Wounds 2015;27(8):229-235 Volume 27 - Issue 8 - August 2015: EVIDENCE OF INTENSIVE AUTOLYTIC DEBRIDEMENT WITH A SELF-ADAPTIVE WOUND DRESSING Alexander M. Reyzelman, DPM and Mher Vartivarian, DPM
Enluxtra also physically evacuates harmful microorganisms from the wound by sequestering them inside the material, and, by chemical binding process, effectively deprives microorganisms of the free water supply essential for their life support and multiplication.
In chronic wounds Enluxtra helps stop chronic inflammation and resume the normal healing process.
In chronic wounds Enluxtra helps stop chronic inflammation and resume the normal healing process.
!
Continuous non-traumatic natural and selective wound cleansing, together with sustainable and balanced moist healing environment, helps reduce chronic inflammation and accelerate wound healing process.
This results in significant drainage and odor reduction.
Continuous non-traumatic natural and selective wound cleansing, together with sustainable and balanced moist healing environment, helps reduce chronic inflammation and accelerate wound healing process.
This results in significant drainage and odor reduction.
Enluxtra has been proven successful on more than 100,000 of the most complex "train wreck" wounds of various etiologies, drainage levels, and types; and is already adopted by leading hospitals such as UCSF Medical Center, San Francisco General Hospital, and San Francisco VA, as well as many other health systems throughout the US.
MEDICARE REIMBURSEMENT CODES
HCPCS A6196 for size 4”x4”
HCPCS A6197 for size 6”x6”
("other gelling fibers" category)
Under the trade name:
ENLUXTRA Humifiber Wound Dressing
Covered for exuding wounds, up to 30 dressings per month.
HCPCS A6196 for size 4”x4”
HCPCS A6197 for size 6”x6”
("other gelling fibers" category)
Under the trade name:
ENLUXTRA Humifiber Wound Dressing
Covered for exuding wounds, up to 30 dressings per month.
Enluxtra is distributed by all major distributors such as McKesson, Cardinal, Medline (and many others)
Always check the manufacturer's prices first to avoid overpricing by other sellers.
Call (888) 519-2297
Call (888) 519-2297
Enluxtra is included in government supply schedules such as FSS and DAPA ( FSS # V797P-4129B; DAPA # SP0200-07-H-0043)